Research programme: HIV fusion inhibitors - Myriad Pharmaceuticals
Alternative Names: MPI-451936Latest Information Update: 25 Sep 2009
At a glance
- Originator Myriad Pharmaceuticals
- Class Small molecules
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 25 Sep 2009 No development reported - Preclinical for HIV infections in USA (PO)
- 31 Jan 2008 This programme is still in active development
- 02 Nov 2005 This programme is still in active development